REQUEST A DEMO
Total
USD $0.00
Search more companies

Alvogen Pharma Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Alvogen Pharma Sp. z o.o. Profile Updated: January 18, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Alvogen Pharma Sp. z o.o. is based in Poland, with the head office in Warsaw. The enterprise currently operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was established on April 05, 2016. The company’s latest financial report indicates a net sales revenue increase of 77.67% in 2020. Its’ total assets recorded a growth of 41.14%. In, 2020, the company’s net profit margin increased by 1.24%.

Headquarters
Ul. Bonifraterska 17
Warsaw; Mazowieckie; Postal Code: 00-203

Contact Details: Purchase the Alvogen Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Alvogen Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Alvogen Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Alvogen Pharma Sp. z o.o. report to view the information.
Incorporation Date:
April 05, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Alvogen Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
77.67%
Total operating revenue
62.47%
Operating profit (EBIT)
-45.58%
EBITDA
-54.97%
Net Profit (Loss) for the Period
-43.12%
Total assets
41.14%
Total equity
1.18%
Operating Profit Margin (ROS)
1%
Net Profit Margin
1.24%
Return on Equity (ROE)
21.39%
Debt to Equity Ratio
4.44%
Quick Ratio
-0.1%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?